Vitoc Vlad's Form 4/A amendment
AmendedMAIA Biotechnology, Inc. (MAIA) · filed Nov 23, 2022
- Accession no.
- 0001127602-22-026326
- Filed
- Nov 23, 2022
- Trade date
- Aug 1, 2022
- Filing delay
- 114 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 2, 2022
This filing lists 2 non-derivative transactions. Open-market purchases total $80.0K. It was filed 114 days after the trade.
This amendment replaces 0000899243-22-027454 (filed Aug 2, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vitoc VladCIK 0001913257 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2022 | Common Stock | PPurchaseAcquired | +6,000 | $5.00 | +$30,000 | 789,121 | Direct | |
| Aug 1, 2022 | Common Stock | PPurchaseAcquired | +10,000 | $5.00 | +$50,000 | 210,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares were purchased in the issuer's initial public offering, which closed on August 1, 2022.
- F2
These securities are beneficially owned by Mr. Vitoc's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.